Literature DB >> 11418279

Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis.

O Mikova1, R Yakimova, E Bosmans, G Kenis, M Maes.   

Abstract

There is now evidence that major depression is accompanied by activation of the inflammatory response system (IRS) as indicated by an increased production of pro-inflammatory cytokines. There is circumstantial evidence implicating pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNFalpha) in the pathogenesis of multiple sclerosis (MS). The aims of the present study were to examine (i) the serum concentrations of interleukin-6 (IL-6), IL-8, TNFalpha, IL-2 receptor (IL-2R) and CC16 (uteroglobulin), an endogenous anti-cytokine, in depressed and MS patients compared to normal controls, and (ii) the effects of treatment with antidepressants on the above IRS variables in depressed patients. Serum TNFalpha was significantly higher in depressed and MS patients than in normal controls. Serum IL-8 was significantly higher in depressed patients than in patients with MS. Serum CC16 was significantly higher in patients with MS than in normal controls and depressed patients. Nonresponders to treatment with antidepressants had significantly higher serum IL-2R and lower serum CC16 concentrations than responders to treatment. The results show that (i) depression is accompanied by activation of the IRS and that this activation is more pronounced in depression than in MS, and (ii) IRS activation in depressed patients is related to a nonresponse to treatment with antidepressants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11418279     DOI: 10.1016/s0924-977x(01)00081-5

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  63 in total

1.  Imipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats.

Authors:  Tatiana Barichello; Graziele Milioli; Jaqueline S Generoso; Andreza L Cipriano; Caroline S Costa; Ana Paula Moreira; Márcia Carvalho Vilela; Clarissa M Comim; Antonio Lucio Teixeira; João Quevedo
Journal:  J Neural Transm (Vienna)       Date:  2011-12-13       Impact factor: 3.575

Review 2.  Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression.

Authors:  Michael Maes
Journal:  Metab Brain Dis       Date:  2012-07-07       Impact factor: 3.584

Review 3.  The cellular and molecular basis of major depressive disorder: towards a unified model for understanding clinical depression.

Authors:  Eleni Pitsillou; Sarah M Bresnehan; Evan A Kagarakis; Stevano J Wijoyo; Julia Liang; Andrew Hung; Tom C Karagiannis
Journal:  Mol Biol Rep       Date:  2019-10-14       Impact factor: 2.316

Review 4.  The inflammation hypothesis in geriatric depression.

Authors:  George S Alexopoulos; Sarah Shizuko Morimoto
Journal:  Int J Geriatr Psychiatry       Date:  2011-03-02       Impact factor: 3.485

Review 5.  A comprehensive review on the role of chemokines in the pathogenesis of multiple sclerosis.

Authors:  Soudeh Ghafouri-Fard; Kasra Honarmand; Mohammad Taheri
Journal:  Metab Brain Dis       Date:  2021-01-06       Impact factor: 3.584

6.  Neuropathic pain-induced depressive-like behavior and hippocampal neurogenesis and plasticity are dependent on TNFR1 signaling.

Authors:  Anna Dellarole; Paul Morton; Roberta Brambilla; Winston Walters; Spencer Summers; Danielle Bernardes; Mariagrazia Grilli; John R Bethea
Journal:  Brain Behav Immun       Date:  2014-06-02       Impact factor: 7.217

7.  Depression in patients with rheumatoid arthritis: description, causes and mechanisms.

Authors:  Mary Margaretten; Laura Julian; Patricia Katz; Edward Yelin
Journal:  Int J Clin Rheumtol       Date:  2011

Review 8.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections.

Authors:  Enrico Domenici; David R Willé; Federica Tozzi; Inga Prokopenko; Sam Miller; Astrid McKeown; Claire Brittain; Dan Rujescu; Ina Giegling; Christoph W Turck; Florian Holsboer; Edward T Bullmore; Lefkos Middleton; Emilio Merlo-Pich; Robert C Alexander; Pierandrea Muglia
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

Review 10.  Neuroimmunomodulation in depression: a review of inflammatory cytokines involved in this process.

Authors:  Helena M Abelaira; Gislaine Z Réus; Fabricia Petronilho; Tatiana Barichello; João Quevedo
Journal:  Neurochem Res       Date:  2014-07-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.